Dsm Ip Assets B.V Patent Portfolio Statistics

tip_user1

Dsm Ip Assets B.V.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Dsm Ip Assets B.V. look like?

Assignee Art Units
Total Applications: 3,638 1,912,958
Granted Patents: 1,995 1,009,391
Grant Index 60.2% ↓ 66.44%
Abandoned/Rejected Applications: 1,319 (39.8%) 509,877 (33.56%)
In-Process Applications: 323 393,690
Average Grant Time: 3.05 Years ↑ 2.8 Years
Average Office Actions: 1.92 ↑ 1.74

Which Technology Area Dsm Ip Assets B.V. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 289
1656 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 173
1621 Organic Chemistry 120
Opap Parked GAU 118
1711 Coating, Etching, Cleaning, Single Crystal Growth 116

How many patents are Dsm Ip Assets B.V. filing every year?

Year Total Applications Predicted
2022 0* 646
2021 95* 588
2020 148 522
2019 126 126
2018 141 –
2017 144 –
2016 139 –
2015 172 –
2014 220 –
2013 170 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Dsm Ip Assets B.V. in USPTO?

Publication number: US20220096519A1
Application number: 17/619,467

Abstract:
The present invention relates to a solid pharmaceutical dosage form comprising at least one spray dried formulation of vitamin B12 and at least one further active pharmaceutical ingredient. Said at least one further active pharmaceutical ingredient is preferably metformin or a pharmaceutical acceptable salt thereof. When manufacturing the dosage form of the invention, uniformity of content is excellent.

Publication date: 2022-03-31
Applicant: Dsm Ip Assets B.V.
Inventors: Misic Zdravka

Publication number: None
Application number: 17/619,474

Abstract:
–

Publication date: –
Applicant: Dsm Ip Assets B.V.
Inventors: Misic Zdravka

Publication number: US20220090032A1
Application number: 17/541,565

Abstract:
The present invention relates a variant polypeptide having geranylgeranyl pyrophosphate synthase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a geranylgeranyl pyrophosphate synthase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids at positions 92, 100 or 235 said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having geranylgeranyl pyrophosphate synthase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.

Publication date: 2022-03-24
Applicant: Dsm Ip Assets B.V.
Inventors: Priscilla Zwartjens

How are Dsm Ip Assets B.V.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/619,467 Solid Pharmaceutical Dosage Form Comprising Spray Dried Vitamin B12 Docketed New Case – Ready for Examination OPAP Central, Docket
17/619,474 Composition Comprising Metformin Hci, Vitamin B12 And At Least One Flow Additive Sent to Classification contractor – –
17/541,565 Geranylgeranyl Pyrophosphate Synthases Docketed New Case – Ready for Examination OPAP Central, Docket
17/615,225 Use Of Benzoic Acid And Essential Oil Compounds For Improving Growth Performance Docketed New Case – Ready for Examination OPAP Central, Docket
17/613,765 Selective Hydrogenation Of Alkynes To Alkenes In The Presence Of A Phosphorus Compound And An Organic Sulphur Compound Docketed New Case – Ready for Examination OPAP Central, Docket